MedTech Dive May 9, 2023
By Nick Paul Taylor

Dive Brief:

  • The head of the Food and Drug Administration has warned the U.S. needs to be “nimble in the use and regulation of large language models” to avoid being “swept up quickly by something that we hardly understand.”
  • FDA Commissioner Robert Califf, speaking Monday at the 2023 Science for Patient Engagement Symposium, said the models are “ushering in the revolution that many of us were hoping for,” but cautioned that the sector will need to be regulated appropriately.
  • Califf identified bias as a specific concern, noting that the models and other algorithms “evolve after they are put into practice” and will likely need continuous adjustment throughout the life cycle to remain accurate.

Dive Insight:

Large language models...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Regulations, Technology
Why FDA Commissioner Robert Califf is 'concerned' about the incoming administration
A flurry of health tech deals announced ahead of JPM
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
FDA offers new draft guidance to developers of AI-enabled medical devices
Chevron’s Fall And Its Impact On Medical AI

Share This Article